BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

US FDA Grants Fast Track Designation to T-MAXIMUM’s Allogeneic CAR-T Therapy for Recurrent Glioblastoma

T-MAXIMUM PHARMACEUTICAL Inc. ("T-MAXIMUM") announced that its investigational allogeneic CAR-T cell therapy MT027 has been granted Fast Track Designation ...

September 02, 2026 | News

Astellas Reaches US Government Agreement to Lower Medicaid Drug Prices, Strengthen Medicine Supply Chain

Agreement supports commitment to patient access, affordability and innovation – Astellas Pharma Inc. announced that it has reached an agreemen...

September 02, 2026 | News

DualityBio, Genentech Ink $1B-Plus Deal to Develop Next-Generation ADCs Against Drug-Resistant Tumours

Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming furth...

August 31, 2026 | News

Formosa Pharmaceuticals Files European CTA for TSY-110, Potential First Kadcyla Biosimilar in Regulated Markets

TSY-110 is positioned to become the first biosimilar alternative to Roche's Kadcyla® (ado-trastuzumab emtansine) in major regulated markets. -- F...

August 31, 2026 | News

Thermo Fisher Launches EMPAD G2 Detector to Advance High-Speed 4D STEM Imaging

Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Thermo Scientific™ EMPAD™ G2 detector, a new detector design...

August 28, 2026 | News

PENTAX Medical, MAGENTIQ EYE Expand AI-Assisted Colonoscopy Partnership Globally

Expanded agreement combines PENTAX Medical's continued investment in flexible reusable endoscopy with MAGENTIQ's clinically validated AI capabilities, expa...

August 28, 2026 | News

Monod Bio, SignalChem Biotech Ink Licensing Deal to Advance AI-Designed Protein Technologies

Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. announced a n...

August 28, 2026 | News

ReviR Therapeutics’ RTX-117 Secures FDA Rare Pediatric Disease Designation for Charcot-Marie-Tooth Disease

Designation supports the global development of RTX-117 and may provide potential future access to a transferable Priority Review Voucher, subject to approv...

August 28, 2026 | News

Biosidus Expands Biologics Manufacturing Capacity with New Bioreactor Plant in Argentina

Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announ...

August 28, 2026 | News

US FDA Approves BeOne’s TEVIMBRA-ZIIHERA Combination for First-Line HER2+ Gastroesophageal Cancer

TEVIMBRA plus ZIIHERA and chemotherapy is the first and only immunotherapy-based regimen to deliver more than two years of median OS in first-line HER2+ ...

August 27, 2026 | News

Celltrion Launches 300 mg Omlyclo Omalizumab Biosimilar Across Key European Markets

Omlyclo® (omalizumab) 300 mg launched in key European markets including Germany, the UK and France, with rollout to expand across Europe by ye...

August 26, 2026 | News

Biocon Partners with Innomar Strategies to Strengthen Canada Supply Chain

Biocon has partnered with Innomar Strategies, a healthcare services and logistics company, to strengthen its pharmaceutical supply chain and distribution n...

August 25, 2026 | News

Taiwan’s Anbogen Partners University of Tokyo to Advance ABT-301 Across Solid Tumours

Anbogen Therapeutics Inc. (TPEx: 7784) ("Anbogen" or the "Company"), a clinical-stage precision oncology company, announced that it has entered into a Coll...

August 25, 2026 | News

South Korea’s Rznomics Joins Lilly Gateway Labs in US to Accelerate RNA Gene Therapies

Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly ...

August 25, 2026 | News

Stay Connected